MedTrace Logo

Family Caregiving Role Adjustment and Dyadic Mutuality

NCT02566174 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2019-12-16

No results posted yet for this study

Summary

Background:

Cancer causes changes in the lives of patients and in the lives of their caregivers. Patients and caregivers feel stress and they affect each other as they deal with these changes. They each cope with cancer diagnosis and treatment on their own. They also cope together. Researchers want to explore this shared change of roles and responsibilities. They will do this by gaining insight into the social experience of cancer caregiving. They also want to better understand the ways caregiver/patient teams manage the cancer diagnosis and experience. This can help find new ways to support caregivers and their patients.

Objective:

To explore the shared change of roles and responsibilities of patients and caregivers by studying the social experience of cancer caregiving.

Eligibility:

English speakers ages 18 and older who are one of the following:

A cancer patients at the NIH Clinical Center (CC)

A caregiver of a CC cancer patient

Design:

Participants will have been screened by the CC.

Patients and caregivers will be interviewed separately. This will last up to an hour and a half.

Participants will complete online surveys.

Participants may have a follow-up phone interview. This will last up to 15 minutes.

Conditions

  • Family Caregiver and Patient Mutual Negotiation of Roles and Responsibilities

Sponsors & Collaborators

  • National Institutes of Health Clinical Center (CC)

    lead NIH

Principal Investigators

  • Margaret F Bevans, R.N. · National Institutes of Health Clinical Center (CC)

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-01
Primary Completion
2017-08-24
Completion
2019-09-18

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02566174 on ClinicalTrials.gov